- Home
- PMN vs HKPD Comparison
PMN vs HKPD Comparison
Compare PMN & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- HKPD
- Stock Information
- Founded
- PMN 2004
- HKPD 2016
- Country
- PMN Canada
- HKPD Hong Kong
- Employees
- PMN N/A
- HKPD N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- HKPD Other Pharmaceuticals
- Sector
- PMN Health Care
- HKPD Health Care
- Exchange
- PMN Nasdaq
- HKPD Nasdaq
- Market Cap
- PMN 22.3M
- HKPD 20.9M
- IPO Year
- PMN N/A
- HKPD 2025
- Fundamental
- Price
- PMN $0.56
- HKPD $1.30
- Analyst Decision
- PMN Strong Buy
- HKPD
- Analyst Count
- PMN 3
- HKPD 0
- Target Price
- PMN $4.33
- HKPD N/A
- AVG Volume (30 Days)
- PMN 786.1K
- HKPD 193.4K
- Earning Date
- PMN 11-13-2025
- HKPD 08-14-2025
- Dividend Yield
- PMN N/A
- HKPD N/A
- EPS Growth
- PMN N/A
- HKPD N/A
- EPS
- PMN N/A
- HKPD N/A
- Revenue
- PMN N/A
- HKPD $20,313,818.00
- Revenue This Year
- PMN N/A
- HKPD N/A
- Revenue Next Year
- PMN N/A
- HKPD N/A
- P/E Ratio
- PMN N/A
- HKPD N/A
- Revenue Growth
- PMN N/A
- HKPD 21.72
- 52 Week Low
- PMN $0.38
- HKPD $0.81
- 52 Week High
- PMN $1.59
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- PMN 63.37
- HKPD 46.05
- Support Level
- PMN $0.39
- HKPD $1.19
- Resistance Level
- PMN $0.61
- HKPD $1.52
- Average True Range (ATR)
- PMN 0.04
- HKPD 0.14
- MACD
- PMN 0.02
- HKPD -0.03
- Stochastic Oscillator
- PMN 80.05
- HKPD 12.70
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.